JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB259157

Human SSR4 knockout HEK-293T cell lysate

Be the first to review this product! 리뷰 제출

|

(0 출판물)

SSR4 KO cell lysate available now. KO validated. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 10 bp deletion in exon 1 and 8 bp deletion in exon 1.
2 이미지
Sanger Sequencing - Human SSR4 knockout HEK-293T cell lysate (AB259157)
  • Sanger seq

Unknown

Sanger Sequencing - Human SSR4 knockout HEK-293T cell lysate (AB259157)

Allele-1 : 10 bp deletion in exon 1

Sanger Sequencing - Human SSR4 knockout HEK-293T cell lysate (AB259157)
  • Sanger seq

Unknown

Sanger Sequencing - Human SSR4 knockout HEK-293T cell lysate (AB259157)

Allele-2 : 8 bp deletion in exon 1

주요 정보

세포 유형

HEK-293T

Species or organism

Human

조직

Kidney

Knockout 검증

Sanger Sequencing

Mutation 정보

Knockout achieved by using CRISPR/Cas9, 10 bp deletion in exon 1 and 8 bp deletion in exon 1.

제품 세부 정보

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

제품 구성

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab259157-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human SSR4 knockout HEK293T cell lysate", "number":"AB259157-CMP01", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HEK293T cell lysate", "number":"AB259157-CMP02", "productcode":"" } ] } } }

특성 및 보관 정보

유전자명
SSR4
유전자 편집 종류
Knockout
유전자 편집 방식
CRISPR technology
Knockout 검증
Sanger Sequencing
배송 시 보관 조건
Ambient - Can Ship with Ice
적절한 단기 보관 조건
-20°C
적절한 장기 보관 조건
-20°C

추가 정보

This supplementary information is collated from multiple sources and compiled automatically.

SSR4 also known as TRG4 or CDG1S is a subunit of the signal recognition particle receptor responsible for the translocation of proteins across the membrane of the endoplasmic reticulum. With an approximate mass of 24 kDa SSR4 is expressed predominately in tissues with high secretory functions such as the liver and pancreas. It plays an important role in facilitating the proper insertion and folding of nascent polypeptide chains by cooperating with other components of the translocation machinery.
Biological function summary

SSR4 functions as part of the signal sequence receptor (SSR) complex. This complex is essential for the targeting and translocation of newly synthesized proteins into the endoplasmic reticulum lumen. SSR4 interacts directly with signal sequences of nascent polypeptides to ensure their correct orientation and localization during protein synthesis. Proper functioning of SSR4 is necessary for the homeostasis of the cellular secretory pathway.

Pathways

SSR4 is involved in the protein translocation pathway which is essential for protein sorting and trafficking. This pathway intersects with the unfolded protein response (UPR) pathway which maintains protein homeostasis under stress conditions. In these pathways SSR4 collaborates with proteins like Sec61 to mediate translocation and assist in protein folding. Disruptions in these pathways can lead to cellular dysfunction and stress-related responses.

Defects or alterations in SSR4 are linked to congenital disorders of glycosylation (CDGs) which affect multiple organ systems. Altered glycoprotein production in these disorders results from impaired protein translocation demonstrating SSR4’s influence on glycoprotein processing. Furthermore SSR4 may interact with proteins like glycosyltransferases affecting their function in cellular processes and contributing to the broad clinical spectrum observed in CDGs.

품질 관리

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

제품 프로토콜

Product promise

저희는 고품질 시약으로 고객님의 연구를 서포트하고자 최선을 다하고 있으며, 모든 단계에서 함께 하겠습니다. 만약 제품이 기대한 성능을 보이지 않을 경우에도 Product Promise로 보호받으실 수 있습니다.
자세한 내용은 이용 약관을 확인해 주세요.

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com